DoD Prostate Cancer, Physician Research Award

The DoD Prostate Cancer, Physician Research Award is a forecasted federal funding opportunity issued by the U.S. Department of Defense through the Department of the Army, U.S. Army Medical Research Acquisition Activity under the Congressionally Directed Medical Research Programs. The opportunity is part of the fiscal year 2026 Prostate Cancer Research Program and is intended to support physicians pursuing careers in prostate cancer research while continuing to maintain clinical responsibilities. The award mechanism is specifically designed for early-career clinician investigators who are either in the final year of an accredited medical residency or fellowship program or within five years of beginning a faculty appointment. The funding opportunity seeks to strengthen the future workforce of physician-scientists focused on prostate cancer and accelerate clinically relevant discoveries aligned with Department of Defense priorities. The Physician Research Award supports mentored research experiences that combine research training, career development, and scientific investigation. Applications submitted under this opportunity must address at least one of the fiscal year 2026 Prostate Cancer Research Program Overarching Challenges. The program emphasizes the development of physicians who can bridge patient care and translational research. The Principal Investigator is expected to demonstrate commitment to a long-term career in prostate cancer research, while mentors are expected to provide substantial guidance and oversight. The opportunity highlights mentorship as a central component, requiring at least one mentor with demonstrated expertise in prostate cancer research and a successful track record of mentoring investigators. The award also requires a detailed researcher development plan that outlines how the investigator will acquire the skills and competencies necessary to become an independent researcher. The funding opportunity is categorized under Science and Technology and other Research and Development and is listed under Assistance Listing 12.420, Military Medical Research and Development. The estimated total program funding for this opportunity is $8,800,000, with approximately eight awards anticipated. The announcement does not specify an award ceiling or award floor in the forecast notice. Cost sharing or matching funds are not required for this opportunity. The funding instrument type is a grant, and the opportunity is categorized as discretionary funding. While the forecast notice provides limited information regarding allowable costs, applicants should anticipate that eligible expenses will support research activities, career development efforts, mentorship structures, and associated scientific personnel or project-related costs consistent with Department of Defense biomedical research funding mechanisms. Eligibility for the opportunity is listed as unrestricted, meaning the competition is open to all entity types permitted under federal grant regulations, subject to any clarifications that may appear in the full solicitation upon release. Despite the unrestricted entity designation, the scientific eligibility requirements are focused specifically on physician investigators meeting the early-career criteria outlined in the announcement. Applicants are expected to hold clinical duties and demonstrate eligibility through their residency, fellowship, or faculty appointment timeline. The program announcement does not currently identify geographic restrictions, suggesting nationwide eligibility for U.S.-based applicants and institutions. Organizations submitting applications will likely need to comply with standard federal registration requirements, including registration in applicable federal systems prior to submission. The forecasted notice indicates that the official opportunity posting is expected on May 20, 2026. The estimated application due date is September 15, 2026. The estimated award date and project start date are both September 30, 2027. Because the opportunity is currently forecasted, detailed application instructions, required forms, evaluation criteria, and submission mechanics are not yet fully available. However, applicants should anticipate a standard Department of Defense biomedical research application process involving electronic submission systems and detailed research proposals. The opportunity references the electronic Biomedical Research Application Portal, or eBRAP, which commonly serves as the pre-application and communication platform for Congressionally Directed Medical Research Programs opportunities. The announcement does not specify a letter of intent or pre-application requirement at this stage. The funding opportunity includes contact information for the eBRAP Help Desk, which serves as the primary support resource for applicants. The listed phone number is 301-682-5507 and the support email is help@eBRAP.org. Additional information regarding the fiscal year 2026 Prostate Cancer Research Program is available through the Congressionally Directed Medical Research Programs pre-announcement webpage referenced in the notice. The current notice represents a forecasted opportunity rather than a final solicitation, so applicants are encouraged to monitor Grants.gov and Department of Defense program communications for the release of the complete funding announcement, application package, evaluation criteria, and detailed submission requirements.

Strong applications will likely demonstrate clear alignment with FY26 PCRP Overarching Challenges, provide meaningful mentorship support from experienced prostate cancer researchers, and include a detailed individualized career development strategy for transitioning to independent prostate cancer research.